AndreaBozzo/ceres-open-data-index huggingface dataset:
Information Memorandum (IM-18-01)

This Information Memorandum (IM) informs title IV-E agencies of the ANPRM (published on March 15, 2018 and 83 FR 11449) and the NPRM regarding implementation of the December 2016 AFCARS final rule (published on March 15, 2018 and 83 FR 11450).

Metadata-only record linking to the original dataset. Open original dataset below.
Alarms in the intensive care unit: how can the number of false alarms be reduced?

Many alarms, as they now exist in most monitoring systems, are not usually perceived as helpful by the medical staff because of the high incidence of false alarms. This paper gives an overview of the problems related to their current design and the objectives of monitoring. The current approaches used to improve the situation are then presented from two main standpoints: organizational and behavioural on the one hand, and technical on the other.
Nebraska (NE)

This report presents estimates for measures of substance use and mental health based on the combined 2010 and 2011 National Surveys on Drug Use and Health (NSDUHs). Topics covered include past month substance use (e.g., illicit drugs, marijuana, cocaine, pain relievers, alcohol, tobacco), substance dependence, abuse, and treatment need, past year serious mental illness (SMI), any mental illness (AMI), suicidal thoughts, and major depressive episode (MDE). Resuts are provided for Nebraska for five age groups: 12 to 17, 18 to 25, 26 or older, 18 or older and all persons 12 or older.
2012 Uniform Reporting System (URS) Tables for Georgia

Center for Mental Health Services (CMHS) Uniform Reporting System (URS) Output Tables for 2012. The Uniform Reporting System (URS) is a state and national reporting system collected annually to support the Community Mental Health Services Block Grant program. State Mental Health Authorities report on National Outcome Measures (NOMS), evidence based practices, and utilization measures providing an overview of state mental health delivery systems.
The NSDUH Report: Need for and Receipt of Substance Use Treatment among Blacks

This report uses 2003 to 2011 National Survey on Drug Use and Health (NSDUH) to assess past year need for and receipt of alcohol use treatment and illicit drug use treatment among African Americans or Blacks aged 12 or older in comparison to persons of other racial and ethnic groups. Results are shown by age group, gender, federal poverty level and insurance coverage status.
Patent AT-E399550-T1: [Translated] REMEDIES AND PREVENTIVE AGENTS FOR DIGESTIVE DISEASES CONTAINING DIAMINOTRIFLUOROMETHYLPYRIDINE COMPOUNDS

A digestive system disease therapeutic or preventive agent containing as an active ingredient a diaminotrifluoromethylpyridine derivative represented by the formula (I) or its salt: <CHEM> wherein X is a -CW<1>R<1> group, a -COCOR<2> group, a -CW<1>NHCOR<2> group, a -C(=W<1>)W<2>R<3> group or a -CW<1>N(R<4>)R<5> group; Y is an alkyl group, a -CW<3>R<6> group, a -COCOR<7> group, a -NHCOR<7> group, a -C(=W<3>)W<4>R<8> group, a -(NH)mSO2R<9> group, a -(NH)mSO2OR<10> group or a -(NH)mSO2N(R<11>)R<12> group; each of R<1>, R<6> and R<9> is a chain hydrocarbon group, a monocyclic hydrocarbon group, a polycyclic hydrocarbon group, a monocyclic heterocycle group or a polycyclic heterocycle group; each of R<2> and R<7> is an alkyl group, an alkoxy group, a phenyl group or a phenoxy group; each of R<3>, R<8> and R<10> is an alkyl group, an alkenyl group, an alkynyl group, a cycloalkyl group, a phenyl group or a benzyl group; each of R<4>, R<5>, R<11> and R<12> is an alkyl group; each of W<1>, W<2>, W<3> and W<4> is an oxygen atom or a sulfur atom; and m is 0 or 1.
Cytochrome P450 2E1 polymorphism and nasopharyngeal carcinoma development in Thailand: a correlative study

Background
          Nasopharyngeal carcinoma (NPC) is a rare tumor in most parts of the world but occurs at relatively high frequency among people of Chinese descent. The cytochrome P450 2E1 enzyme (CYP2E1) is responsible for the metabolic activation of nitrosamines, and has been shown to be a susceptibility gene for NPC development in Taiwan [RR = 2.6; 95%CI = 1.2-5.7]. Since there has been only one report of this link, it was decided to investigate the susceptibility of CYP2E1 to NPC development in other populations. Therefore, the correlation between the RsaI polymorphism of this gene and NPC was studied in-patients including Thai and Chinese in Thailand. The present study comprised 217 cases diagnosed with NPC and 297 healthy controls.
        
        
          Results
          Similar to the result found in Taiwanese, a homozygous uncut genotype demonstrated a higher relative risk both when all cases were analyzed [RR = 2.19; 95%CI = 0.62-8.68] or individual racial groups, Thai [RR = 1.51; 95%CI = 0.08-90.06] or Chinese [RR = 1.99; 95%CI = 0.39-10.87]. The ethnicity-adjusted odds ratio is 2.39 with 95%CI, 0.72-7.89.
        
        
          Conclusions
          Though our finding was not statistically significant due to the moderate sample size of the study, similarity to the study in Taiwan with only a slight loss in precision was demonstrated. The higher RR found for the same genotype in distinct populations confirmed that CYP2E1 is one of several NPC susceptibility genes and that the RsaI minus variant is one mutation that affects phenotype.
The acute effects of body position strategies and respiratory therapy in paralyzed patients with acute lung injury

Background:
          Routine turning of critically ill patients is a standard of care. In recent years, specialized beds that provide automated turning have been introduced. These beds have been reported to improve lung function, reduce hospital-acquired pneumonia, and facilitate secretion removal. This trial was designed to measure the physiological effects of routine turning and respiratory therapy in comparison with continuous lateral rotation (CLR).
        
        
          Methods:
          The study was a prospective, quasi-experimental, random assignment, trial with patients serving as their own controls. Paralyzed, sedated patients with acute respiratory distress syndrome were eligible for study. Patients were randomized to receive four turning and secretion management regimens in random sequence for 6 h each over a period of 24 h: (1) routine turning every 2 h from the left to right lateral position; (2) routine turning every 2 h from the left to right lateral position including a 15-min period of manual percussion and postural drainage (P&PD); (3) CLR with a specialized bed that turned patients from left to right lateral position, pausing at each position for 2 min; and (4) CLR with a specialized bed that turned patients from left to right lateral position pausing at each position for 2 min, and a 15-min period of percussion provided by the pneumatic cushions of the bed every 2 h.
        
        
          Results:
          Nineteen patients were entered into the study. There were no statistically significant differences in the measured cardiorespiratory variables. There was a tendency for the ratio of partial pressure of arterial oxygen to fractional inspired oxygen concentration (PaO2/FIO2) to increase (174 ± 31 versus 188 ± 36; P = 0.068) and for the ratio of deadspace to tidal volume (Vd/Vt) to decrease (0.62 ± 0.18 versus 0.59 ± 0.18; P = 0.19) during periods of CLR, but these differences did not achieve statistical significance. There were statistically significant increases in sputum volume during the periods of CLR. The addition of P&PD did not increase sputum volume for the group as a whole. However, in the four patients producing more than 40 ml of sputum per day, P&PD increased sputum volume significantly. The number of patient turns increased from one every 2 h to one every 10 min during CLR.
        
        
          Conclusion:
          The acute effects of CLR are undoubtedly different in other patient populations (spinal cord injury and unilateral lung injury). The link between acute physiological changes and improved outcomes associated with CLR remain to be determined.
Compound 526359: 3-Bromo-1,2,6,9-tetrachloro-dibenzo-p-dioxin

Chemical compound data from PubChem database. IUPAC Name: 3-bromo-1,2,6,9-tetrachlorodibenzo-p-dioxin. Molecular Formula: C12H3BrCl4O2. Molecular Weight: 400.9. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Drug therapy and adverse drug reactions to terbutaline in obstetric patients: a prospective cohort study in hospitalized women

Background
          Adverse drug reactions (ADR's) could be expected more frequently in pregnant women. This study was performed in order to identify ADR's to tocolytic drugs in hospitalised pregnant women.
        
        
          Methods
          A prospective cohort study was performed in two General Hospitals of the Instituto Mexicano del Seguro Social (IMSS) in Mexico City. Two hundred and seven women undergoing labor, premature labor, threatened abortion or suffering any obstetric related disease were included. Drug prescription and signs and symptoms of any potential ADR were registered daily during the hospital stay. Any potential ADR to tocolytic drugs was evaluated and classified by three of the authors using the Kramer's algorithm.
        
        
          Results
          Of the 207 patients, an ADR was positively classified in 25 cases (12.1%, CI95% 8.1 to 17.5%). All ADR's were classified as minor reactions. Grouping patients with diagnosis of threatened abortion, premature labor or under labor (n= 114), 24 ADR's were related to terbutaline, accounting for a rate of 21.1 ADR's per 100 obstetric patients. Obstetric patients suffering an ADR were older than obstetric patients without any ADR. However, the former received less drugs/day × patient-1 and had a shorter hospital stay (p < 0.05) whereas the dose of terbutaline was similar between the two groups. Terbutaline inhibited uterine motility in women with and without any ADR at a similar rate, 70 and 76% respectively (x2 = 0.07; p = 0.8).
        
        
          Conclusion
          Terbutaline, used as a tocolytic drug, was related to a high frequency of minor ADRs and to a high rate of effcicacy.
2011-2012 NSDUH Estimated Totals by State

2011-2012 NSDUH Model-Based Estimated Totals (in Thousands). Topics covered include past month substance use (e.g., illicit drugs, marijuana, cocaine, pain relievers, alcohol, tobacco), substance dependence, abuse, and treatment need, past year serious mental illness (SMI), any mental illness (AMI), suicidal thoughts, and major depressive episode (MDE). Results are provided by State and for five age groups: 12 to 17, 18 to 25, 26 or older, 18 or older and all persons 12 or older.
Patent AT-E399835-T1: [Translated] NATURAL GAS HYDRATE AND METHOD FOR THE PRODUCTION THEREOF

A method for the production of the natural gas hydrate characterized by the steps of: combining natural gas and water to form a natural-gas water system and an agent adapted to reduce the natural gas-water interfacial tension to form a natural-gas water-agent system, allowing the natural gas-water-agent system to reach equilibrium at elevated pressure and ambient temperature and reducing the temperature of the natural gas-water-agent system to initiate the formation of the natural gas hydrate.
Compound 525561: N,N-Dimethyl-N'-(3-bromophenyl)-p-chlorobenzamidine

Chemical compound data from PubChem database. IUPAC Name: N'-(3-bromophenyl)-4-chloro-N,N-dimethylbenzenecarboximidamide. Molecular Formula: C15H14BrClN2. Molecular Weight: 337.64. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
2010 State Profile — New York

This state profile includes data from facilities in New York that reported to N-SSATS for the survey reference date March 31, 2010. Data were collected on the location, characteristics, services offered, and number of clients in treatment at alcohol and drug abuse treatment facilities (both public and private) in New York. In New York, 1,000 substance abuse treatment facilities were included in the 2010 N-SSATS, reporting that there were 130,171 clients in substance abuse treatment on March 31, 2010. The survey response rate in New York was 96.1%.
Patent AT-E401372-T1: [Translated] HALOGEN-FREE FLAME-RESISTANT THERMOPLASTIC RESIN COMPOSITION

Chemical patent from PubChem database. Patent Number: AT-E401372-T1. Title: Novel Drug Delivery System. Filing Date: 1995-02-03. Inventors: Chen, Wei, Kumar, Raj, Williams, Sarah. Abstract: The present invention discloses a drug delivery system designed to provide targeted and sustained release of therapeutic agents, improving patient com... IPC Classifications: C12N, C12P, A61K. This patent covers 28 claims related to 2 chemical compounds. Useful for intellectual property research, prior art searches, and chemical innovation tracking.
NIMH Repository and Genomics Resources (RGR)

<p>The NIMH Repository and Genomics Resource (RGR) stores biosamples, genetic, pedigree and clinical data collected in designated NIMH-funded human subject studies. The RGR database likewise links to other repositories holding data from the same subjects, including dbGAP, GEO and NDAR. The NIMH RGR allows the broader research community to access these data and biospecimens (e.g., lymphoblastoid cell lines, induced pluripotent cell lines, fibroblasts) and further expand the genetic and molecular characterization of patient populations with severe mental illness.</p>
NSDUH 2020 Person-Level Sampling Weight Calibration Report

Learn about the techniques used to create weights for the 2020 National Survey on Drug Use and Health (NSDUH) at the person level. The report reviews the generalized exponential model (GEM) used in weighting, discusses potential predictor variables, and details the practical steps used to implement GEM. The report also details the weight calibrations, and presents the evaluation measures of the calibrations, as well as a sensitivity analysis.Chapters:Introduces the survey design, weight components, and the remainder of the report.Discusses the impact of the survey interruption on the weighting for 2020.Reviews GEM and outlines how GEM provides a unified approach to adjustments for nonresponse, poststratification, and extreme weights.Discusses potential predictor variables and the strategy for dealing with many predictors.Discusses extreme weights in the GEM.Discusses the control totals for poststratification adjustments.Details the weight calibrations at the dwelling unit level.Discusses the design weight components and weight calibration at the person level.Presents the evaluation measures of calibrated weights and a sensitivity analysis of selected prevalence estimates.Discusses the break-off analysis weights.Appendices include technical details about the model and the evaluations that were performed.
Emergency Temporary Shelters - Limited Stay Exits - By Original  Exit Date

Under <a href="https://chicityclerkelms.chicago.gov/Matter/?matterId=6DEAA6D8-D0E6-EE11-904C-001DD806E058" target="_blank">SO2024-0008386</a>, passed by City Council on 4/17/2024, the Department of Family and Support Services publishes data on the City-operated and City-funded emergency new arrivals shelters. This series of datasets contains data related to the <a href="https://www.chicago.gov/city/en/sites/texas-new-arrivals/home/faqs.html" target="_blank">Limited Stay Policy</a>.

Under this policy, a shelter stay can be extended beyond the initial 60-day period under certain circumstances. This dataset shows the original exit date of those who have exited due to this policy. This dataset does not represent their actual exit date, but rather the date their initial 60-day stay would have ended barring any extensions.
Health Professional Shortage Areas - Mental Health

[<a href='https://files.hawaii.gov/dbedt/op/gis/data/hpsa.pdf' target='_blank' rel='nofollow ugc noopener noreferrer'>Metadata</a>] Mental Health Professional Shortage Areas as of April 2024. Source - Hawaii State Department of Health. Description: Designation of Health Professional Shortage Areas for Mental Health. See also Health Professional Shortage Areas for Dental Health and Primary Care. A Health Professional Shortage Area (HPSA) means any of the following which has a shortage of health professionals: (a) an urban or rural area which is a rational service area for the delivery of health services, (b) a population group, or (c) a public or nonprofit private medical facility. HPSAs are divided into three major categories according to the type of health professional shortage: primary care, dental or mental health HPSAs. For more information about HPSA’s, visit the Hawaii State Department of Health HPSA website at <a href='https://health.hawaii.gov/opcrh/home/health-professional-shortage-area-hpsa/' target='_blank' rel='nofollow ugc noopener noreferrer'>https://health.hawaii.gov/opcrh/home/health-professional-shortage-area-hpsa/</a>. Hawaii Statewide GIS Program staff downloaded data from <a href='https://data.hrsa.gov/data/download?hmpgtitle=hmpg-hrsa-data' target='_blank' rel='nofollow ugc noopener noreferrer'>https://data.hrsa.gov/data/download?hmpgtitle=hmpg-hrsa-data</a> April 2024. Projected to UTM Zone 4 NAD 83 HARN, and clipped to coastline. For additional information, please refer to summary metadata at <a href='https://files.hawaii.gov/dbedt/op/gis/data/hpsa.pdf' target='_blank' rel='nofollow ugc noopener noreferrer'>https://files.hawaii.gov/dbedt/op/gis/data/hpsa.pdf</a> or contact Hawaii Statewide GIS Program, Office of Planning and Sustainable Development, State of Hawaii; PO Box 2359, Honolulu, Hi. 96804; (808) 587-2846; email: <a href='mailto:gis@hawaii.gov' target='_blank' rel='nofollow ugc noopener noreferrer'>gis@hawaii.gov</a>; Website: <a href='https://planning.hawaii.gov/gis' target='_blank' rel='nofollow ugc noopener noreferrer'>https://planning.hawaii.gov/gis</a>.
National Survey of Substance Abuse Treatment Services (N-SSATS-2000)

<p>The National Survey of Substance Abuse Treatment Services (N-SSATS) is designed to collect information from all facilities in the United States, both public and private, that provide substance abuse treatment. N-SSATS provides the mechanism for quantifying the dynamic character and composition of the United States substance abuse treatment delivery system. The objectives of N-SSATS are to collect multipurpose data that can be used to assist the Substance Abuse and Mental Health Services Administration (SAMHSA) and state and local governments in assessing the nature and extent of services provided and in forecasting treatment resource requirements, update SAMHSA's Inventory of Substance Abuse Treatment Services (I-SATS), analyze general treatment services trends, and generate the National Directory of Drug and Alcohol Abuse Treatment Programs and its online equivalent, the Substance Abuse Treatment Facility Locator <a href="http://findtreatment.samhsa.gov">http://findtreatment.samhsa.gov</a>.<br />
Data are collected on topics including facility operation, services offered (assessment, substance abuse therapy and counseling, testing, transitional, and ancillary), primary focus (substance abuse, mental health, both, general health, other), hotline operation, Opioid Treatment Programs and medication dispensed, languages in which treatment is provided, type of treatment provided, number of clients (total and under age 18), number of beds, types of payment accepted, sliding fee scale, special programs offered, facility accreditation and licensure/certification, and managed care agreements.This study has 1 Data Set.</p>
Peg-3350, sodium sulfate, sodium chloride, potassium chloride, sodium ascorbate and ascorbic acid

This prescription kit, manufactured by Teva Pharmaceuticals USA, Inc., contains polyethylene glycol 3350 (PEG-3350), sodium sulfate, sodium chloride, potassium chloride, sodium ascorbate, and ascorbic acid. It's an oral solution used to cleanse the colon before procedures like colonoscopy by causing bowel movements. This information was generated using AI and is provided for informational and research purposes only.
Compound 526070: 1-Hexadecanol, 14-methyl, TMS

Chemical compound data from PubChem database. IUPAC Name: trimethyl(14-methylhexadecoxy)silane. Molecular Formula: C20H44OSi. Molecular Weight: 328.6. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 528290: Benzene, 1,2,3-trimethyl-5-propyl

Chemical compound data from PubChem database. IUPAC Name: 1,2,3-trimethyl-5-propylbenzene. Molecular Formula: C12H18. Molecular Weight: 162.27. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 530700: 2,3,4-Trifluorobenzoic acid, tridec-2-ynyl ester

Chemical compound data from PubChem database. IUPAC Name: tridec-2-ynyl 2,3,4-trifluorobenzoate. Molecular Formula: C20H25F3O2. Molecular Weight: 354.4. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
New Legislation — Public Law (P.L.) 117-328, §5131 of Division FF of the Consolidated Appropriations Act, 2023, Enacted December 29, 2022

This Information Memorandum informs title IV-E agencies of how the Consolidated Appropriation Act, 2023 created a transition period for ending the temporary increase in the Federal Medical Assistance Percentage that has been in effect since January 2020 for title IV-E programs.

Metadata-only record linking to the original dataset. Open original dataset below.
Compound 530518: 5-Bromovaleric acid, pentadecyl ester

Chemical compound data from PubChem database. IUPAC Name: pentadecyl 5-bromopentanoate. Molecular Formula: C20H39BrO2. Molecular Weight: 391.4. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Outpatient and Ambulatory Surgery Consumer Assessment of Healthcare Providers and Systems (OAS CAHPS) survey for hospital outpatient departments - State

A list of the state averages for the OAS CAHPS Survey responses. The OAS CAHPS survey collects information about patients' experiences of care in hospital outpatient departments (HOPDs) and ambulatory surgical centers (ASCs). The data are updated and reported each quarter with data from the most recently completed quarter replacing the oldest quarter of data.